ClinicalTrials.Veeva

Menu

Improving the Health and Social Participation of People With Disabilities From Underrepresented Groups Post COVID

University of Illinois logo

University of Illinois

Status

Enrolling

Conditions

Disabilities Multiple

Treatments

Behavioral: ENGAGE

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05792852
2022-1393
UL1TR002003 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This is a single-arm community-based feasibility study examining recruitment, retention, adherence, and satisfaction with ENGAGE, a community-based intervention designed to address pandemic-related social isolation among people with disabilities. We will also examine preliminary, within-group effects on social participation. The findings of this study will inform a larger trial to examine intervention efficacy.

Full description

Social isolation has been shown to negatively affect physical and mental health, particularly among people with disabilities. Social isolation among people with disabilities has been exacerbated by the COVID-19 pandemic. Even now, people with disabilities remain hesitant to return to social and community activities due to ongoing risk of severe cases and death. Yet, we do not have strong models of intervention designed to address this problem.

ENGAGE is an intervention that may address this gap. ENGAGE was designed to address social and community participation among people with stroke. We have since conducted qualitative research to inform adaptation of ENGAGE to meet the needs of a broader range of people with disabilities related to participation in the context of the ongoing COVID-19 pandemic. This study is the next step in testing and refining the adapted intervention protocol. At the end of this study, we will have a finalized adapted intervention protocol ready for large-scale efficacy testing.

Enrollment

21 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Self-identify as disabled
  • Report problems with social participation
  • Speak English
  • Live in a community setting

Exclusion criteria

  • Severe communication impairment limiting ability to verbally indicate interest in participation

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

21 participants in 1 patient group

ENGAGE
Experimental group
Description:
ENGAGE uses social learning, guided problem-solving and applied skill training to promote social participation among people with disabilities within the context of the COVID-19 pandemic. This is a group intervention using a self-management framework.
Treatment:
Behavioral: ENGAGE

Trial contacts and locations

1

Loading...

Central trial contact

Joy Hammel, PhD; Jessica Kersey, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems